| Mission Therapeutics–Imperial Innovations: investment, 201311 financing round Series B totalling £20m incl existing investor Imperial Innovations |
2013-11-18 |
| Mission Therapeutics–Pfizer: investment, 201311 financing round Series B totalling £20m incl new investor Pfizer Venture Investments |
2013-11-18 |
| Mission Therapeutics–Roche: investment, 201311 financing round Series B totalling £20m incl existing investor Roche Venture Fund |
2013-11-18 |
| Mission Therapeutics–Sofinnova: investment, 201311 financing round Series B totalling £20m incl existing investor Sofinnova Partners |
2013-11-18 |
| Synthace–SEVERAL: investment, 201309 financing round £1.3m led by Sofinnova Green Seed Fund with syndicate of angel investors |
2013-09-24 |
| Pepticom–OTHER: investment, 201308 seed investment |
2013-08-01 |
| Chiesi–Uniqure: gene therapy, 201307–201707 collab developm + commercialisation of hemophila B gene therapy TERMINATED 7/17 |
2013-07-09 |
| Advanced Liquid Logic–CEA: microfluidics technology, 201307 before license from CEA for EWOD microfluidics technology |
2013-07-01 |
| Cristal Therapeutics–Limburg (NL) (govt): investment, 201307 seed financing round expansion with Nedermaas Ventures + Innovatie Fonds Limburg |
2013-07-01 |
| Complix–Gimv: investment, 201306 financing round Series B totalling €12m incl new + co-lead investor Gimv w Biotech Fund Flanders |
2013-06-26 |
| Complix–LCF Rothschild: investment, 201306 financing round Series B totalling €12m incl new + co-lead investor EdRIP |
2013-06-26 |
| Allecra Therapeutics–EMBL: investment, 201304 financing round Series A totalling €15m incl co-investor EMBL Ventures |
2013-04-18 |
| Allecra Therapeutics–Forbion: investment, 201304 financing round Series A totalling €15m incl co-lead investor Forbion |
2013-04-18 |
| Allecra Therapeutics–LCF Rothschild: investment, 201304 financing round Series A totalling €15m incl co-lead investor EdRIP |
2013-04-18 |
| Celgene–Bluebird Bio: CAR-T cell therapy, 201303– collab development for cancer |
2013-03-01 |
| ABF–Genedata: bioinformatics, 2013– supply use of Genedata Selector by AB Enzymes for strain genome data management |
2013-01-01 |
| BioNTech–MAB Discovery: antibody technology, 2013– collab mAb generation using technology of MAB Discovery |
2013-01-01 |
| Boehringer–Qiagen: molecular companion diagnostics, 2013 collab existent incl therascreen EGRF RGQ PCR Kit for Giotrif |
2013-01-01 |
| Kaiser Optical Systems–Endress+Hauser: investment, 2013 acquisition by Endress+Hauser |
2013-01-01 |
| Microphyt–SEVERAL: investment, 2013 funding round over €2m |
2013-01-01 |
| Neuro-Bio–SEVERAL: investment, 2013 seed investment |
2013-01-01 |
| NeuroNova (SE)–Newron: investment, 2013 acquisition of NeuroNova by Newron |
2013-01-01 |
| Omthera Pharmaceuticals–Sofinnova: investment, –2013 existent investor Sofinnova Partners at time of sale to AstraZeneca |
2013-01-01 |
| Pfizer–Mission Therapeutics: DUB inhibitors, 202007– collab expansion with evaluation + option agreem for DUB target validation |
2013-01-01 |
| Viroclinics Biosciences–Gilde Investment: investment, 2013–201708 Gilde Healthcare Services fund acquires majority share SOLD 8/17 |
2013-01-01 |
| PlasmidFactory–Sirion Biotech: gene delivery technology, 201212– collab pronotion of AAV vectors for preclinical ersearch |
2012-12-04 |
| JnJ–Genmab: daratumumab, 201208– license excl ww for developm + manufacture + comercialistion to Janssen Biotech Inc |
2012-08-01 |
| Cristal Therapeutics–BioGeneration Ventures: investment, 201206 seed financing round incl new + co-lead investor BGV |
2012-06-18 |
| Cristal Therapeutics–SEVERAL: investment, 201206 seed financing round led by new investors BGV + Thuja Capital |
2012-06-18 |
| Cristal Therapeutics–Thuja Capital: investment, 201206 seed financing round incl new + co-lead investor Thuja Capital |
2012-06-18 |
| Cristal Therapeutics–Univ Utrecht: investment, 201206 seed financing round incl existing + co-investor Utrecht University Holdings |
2012-06-18 |
| Action Pharma–Abbott: AP214, 201205 acquisition $110m of AP214 by Abbott |
2012-05-01 |
| B Braun–CeGaT: personalised medicine, 201201– collab strategic partnership to expand + internationalise CeGaT’s business |
2012-01-31 |
| JnJ–Phenex: RORgt inhibitors, 2012– collab RnD up to $135m for chronic inflammatory + autoimmune disease w Janssen Biotech |
2012-01-01 |
| KBI BioPharma–Selexis: cell line development, 2012– supply service use of cell lines created using SUREtechnology platform by KBI |
2012-01-01 |
| Qtis/e–Xeltis: investment, 2012 merger of Qtis/e with Xeltis |
2012-01-01 |
| Vivacta–Novartis: investment, 2012 acquisition by Novartis |
2012-01-01 |
| Genmab–Seattle Genetics: antibody-drug conjugates, 201110– license + collab agreem using SG’s ADC technology with HuMax-TF antibody |
2011-10-01 |
| Acacia Pharma–Gilde Investment: investment, 201103 financing round Series A totalling $10m incl existing investor Gilde Healthcare |
2011-03-31 |
| Acacia Pharma–Lundbeck: investment, 201103 financing round Series A totalling $10m incl new investor Lundbeckfond Ventures |
2011-03-31 |
| Acacia Pharma–SEVERAL: investment, 201103 financing round Series A $10m from new investor Lundbeckfond Ventures + existing investor Gilde Healthcare |
2011-03-31 |
| SP Industries–Graham Partners: investment, 201103 acquisition by Graham Partners |
2011-03-01 |
| Genoptix–Novartis: investment, 201701–201703 DIVESTMENT sale €na of Genoptix (excl biopharma business) to Ampersand + 1315 Capital + new managers |
2011-01-24 |
| AVISO GmbH–ALS Automated Lab Solutions: investment, 2011 newly found ALS acquires all assets of AVISO keeping core team intact |
2011-01-01 |
| Boehringer–Minapharm: rec protein production technology, 2011– collab Boehringer early adopter of ProBioGen’s GlymaxX afucosylation technology |
2011-01-01 |
| Cellnovo–LCF Rothschild: investment, 201101 investment by EdRIP |
2011-01-01 |
| Chiesi–Charles River: drug discovery, 2011– collab strategic integrated respiratory drug discovery partnership |
2011-01-01 |
| Meiji Seika Kaisha–Newron: safinamide, 2011– license to develop + manufacture + commercialise safinamide in Asia to Meiji Seika Pharma |
2011-01-01 |
| Novagali Pharma–Santen: investment, 2011 acquisition of Novagali by Santen Pharma Japan |
2011-01-01 |
| Pfizer–KKR: investment, 2011 acquisition of Capsugel from Pfizer by KKR |
2011-01-01 |
| Rebiotix–SEVERAL: investment, 2011 seed financing round $5m |
2011-01-01 |
| Xencor–Selexis: cell line development, 2011– supply service agreem for SUREtechnology for developm of multi-specific antibodies |
2011-01-01 |
| FoldRx–Pfizer: investment, 202009– acquisition $53m by Pfizer |
2010-09-01 |
| Poxel–LCF Rothschild: investment, 201007 financing round Series A totalling €16m incl lead investor EdRIP |
2010-07-08 |
| Aircraft Medical–Medtronic: investment, 2010 (date ca.) aquisition $110m in cash by Medtronic |
2010-01-01 |
| China National Nuclear–ITM: radiopharmaceuticals, 2010– collab strategic partnership with CIRC in China |
2010-01-01 |
| Shionogi–Stallergenes: antiallergic, 2010– collab developm + registration + marketing in JP of immunotherapy tablets |
2010-01-01 |
| Probiodrug–Bellevue: investment, 200911 financing round Series B totalling €36m incl new + lead investors BB Biotech + EdRIP |
2009-11-02 |
| Probiodrug–Biogen Idec: investment, 200911 financing round Series B totalling €36m incl new + co-investor Biogen Idec New Ventures |
2009-11-02 |
| Probiodrug–LCF Rothschild: investment, 200911 financing round Series B totalling €36m incl new + lead investors BB Biotech + EdRIP |
2009-11-02 |
| Probiodrug–Life Sciences Partners: investment, 200911 financing round Series B totalling €36m incl new + co-investor LSP |
2009-11-02 |
| Peplin–Leo Pharma: investment, 2009 acquisition of Peplin Inc by Leo Pharma A/S |
2009-01-01 |
| Sanofi–Oxford BioMedica: ophthalmic gene therapy, 2009–202006 collab developm + commerc Sanofi RIGHTS RETURNED 6/20 |
2009-01-01 |
| BioNTech–SEVERAL: investment, 2008 seed financing round |
2008-01-01 |
| ClinPhone–Parexel: investment, 2008 acquisition of ClinPhone by Parexel |
2008-01-01 |
| Isoprime–Elementar: investment, 2008 acquisition of Isoprime Ltd by Elementar Analysensysteme GmbH |
2008-01-01 |
| KLIFO–PERSON: investment, 2008 acquisition of KLIFO A/S by Alejandra Mørk who joins as CEO |
2008-01-01 |
| Reapplix–SEED Capital: investment, 2008 founding investor SEED Capital |
2008-01-01 |
| Servier–Vernalis: cancer drugs, 2007– collab fragment + structure-based drug discovery |
2007-01-01 |
| Umetrics–MKS Instruments: investment, 2006 acquisition by MKS Instruments |
2006-01-01 |
| EOS Imaging–LCF Rothschild: investment, 200511 investment by EdRIP |
2005-11-01 |
| Actelion–Enamine: chemical compound library, 2005– collab supply of screening compound library to Actelion |
2005-01-01 |
| UroGène–Pierre Fabre: investment, 2005 acquisition of UroGène by Groupe Pierre Fabre |
2005-01-01 |
| UCB–Amgen: therapeutic antibodies, 2004– collab + license RnD + marketing antibody products targeting protein sclerostin |
2004-01-01 |
| Chandler Instruments–AMETEK: investment, 2003 acquisition of Chandler Instruments by AMETEK |
2003-01-01 |
| Grabner Instruments–Chandler Instruments: investment, 2002 acquisition of Grabner by Chandler |
2002-01-01 |
| Biocentric–Hain Lifescience: molecular diagnostics, 2001– exclusive distributor of Hain products in France |
2001-01-01 |
| Per-Form Hungária–Danaher: mass spectrometer, 201909 existent distributor for Sciex technology in Hungary since 2001 |
2001-01-01 |
| Selexis–SEVERAL: investment, 2001 seed financing CHF100k |
2001-01-01 |
| Traceless Materials–b.value: investment, 202104 seed financing round totalling lower €7-digit incl investor b.value AG |
2000-04-01 |
| Traceless Materials–High-Tech Gründerfonds: investment, 202104 seed financing round totalling lower €7-digit incl investor HTGF |
2000-04-01 |
| Traceless Materials–Planet A: investment, 202104 seed financing round totalling lower €7-digit incl investor Planet A |
2000-04-01 |
| Traceless Materials–SEVERAL: investment, 202104 seed financing round lower €7-digit from Planet A + HTGF + b.value |
2000-04-01 |
| Boehringer Mannheim–Roche: investment, 1998 acquisition by Roche |
1998-01-01 |
| Eurofins–SEVERAL: investment, 199710 IPO |
1997-10-24 |
| Hoechst–Clariant: investment, 1997 acquisition of Hoechst Speciality Chemical Business by Clariant |
1997-01-01 |
| Brechbühler–Phenomenex: chromatography consumables, 1991–201708 distribution in Switzerland by Brechbühler TERMINATED 9/17 |
1991-01-01 |
| Commonwealth Holdings–MassMutual: investment, 1990 acquisition $150m of Oppenheimer Management Corp from British & Commonwealth Holdings plc |
1990-01-01 |
| Agilent–Akoya Biosciences: IHC diagnostics, 202301– collab developm + marketing solutions integrating Dako Omnis instrument + PhenoImager HT system |
|
| Brainomix–Tencent: investment, 202112 financing round Series B totalling £16m incl new + co-investor Tencent Holdings |
|
| Brainomix–Univ Oxford: investment, 202112 financing round Series B totalling £16m incl co-investor Oxford University Innovation Fund |
|
| Cellestia Biotech–SEVERAL: investment, <2017 seed financing round Series A CHF0.5m |
|
| Cellestia Biotech–SEVERAL: investment, <2017 seed financing round Series B CHF2.3m |
|
| Epsilen Bio–San Raffaele: epigenetics, 202006– collab strategic incl license agreem for epigenetic sliencing technology with SR-Tiget |
|
| Evonik–Univ Mainz: lipid vectors, 202402– license for rPEG lipids for nucleic acid delivery from Univ Mainz |
|
| Mind NRG–Minerva Neurosciences: investment, before 202008 acquisition of Mind NRG (CH) by Minerva Neurosciences |
|
| OTHER–Novartis: investment, 201401 acquisition of biologics manufacturing faciltiy in Longmont CO by AveXis |
|
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
1 2 3 ... 95 96 97
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
